Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation

Sparad:

Bibliografiska uppgifter
I publikationen:	Pharmaceuticals vol. 18, no. 8 (2025), p. 1157-1189
Huvudupphov:	Niazi, Sarfaraz K
Utgiven:	MDPI AG
Ämnen:	Food & Drug Administration > FDA United States > US Germany Monoclonal antibodies Product quality Collaboration Real time Batch processes Process controls Biological products Pharmaceutical industry Capital expenditures Batch processing Manufacturing Cost control 19th century Product testing
Länkar:	Citation/Abstract Full Text + Graphics Full Text - PDF
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!

Lägg till första kommentaren!